The purpose of the Drug Deal Disclosure Act is to increase transparency in drug pricing agreements between the government and pharmaceutical manufacturers. It aims to ensure that the public has access to information about pricing deals that could affect drug costs and healthcare spending. Key provisions of the Act require the Department of Health and Human Services (HHS) to publicly release various documents related to drug pricing agreements within 30 days of the law's enactment.